AVCNF logo

AVCNF Avicanna Inc.

Other OTC · Drug Manufacturers - Specialty & Generic · Healthcare

$0.06
-0.00 (-4.47%)

Avicanna Inc., a biopharmaceutical firm headquartered in Toronto, Canada, and founded in 2016, is actively engaged in the research, development, and commercialization of scientifically validated products for both global medical and consumer health markets. The company's comprehensive scientific framework encompasses R&D and clinical trials, often undertaken in collaboration with Canadian academic …

Market Cap: $8.15Mwww.avicanna.com

Price

No data yet.

Social Signal Score

40
5d
—
30d
37
3 mentions
—
60d
40
4 mentions
—
90d
43
6 mentions
—
news: 6

Revenue

$5.58M+78520.65%
$-282.3K$2.04M$4.37M$6.70M
Sep 2017Sep 2026

Analyst Estimates

FY2025
$0.07
$0.07–$0.07
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Aras Azadian Mba
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
112
Beta
0.33
Country
CA
Piotroski score
2 / 9 (Weak)
Altman Z-score
-4.84
www.avicanna.com